SAFETY AND EFFICACY OF VESUSTEN® FOR PATIENTS WITH OVERACTIVE BLADDER
- Autores: Pushkar D.Y.1, Kupriyanov Y.A1, Gamidov S.I2, Krivoborodov G.G3, Spivak L.G4,5, Al-Shukri S.K.6,7, Lerman D.M8, Gomberg V.G9, Bogdan E.N10, Shchukin V.L11, Chibirov K.H12, Gelashvili V.V13, Gural A.K14, Keshishchev N.G15, Staroselskaia M.A16, Bastrikova N.A16
-
Afiliações:
- A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of Russia
- National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of Russia
- Pirogov Russian National Research Medical University
- I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia
- LLC «Family polyclinic No. 4»
- FGBOU VO Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation
- LLC «MK-Med»
- LLC «Chaika Clinics»
- GBUZ «City Geriatric Health Center»
- LLC «Aurora Medi»
- LLC «Research Center Eco-safety»
- FSBI «SPb NIIF» of the Ministry of Health of Russia
- FSBI «Clinical Hospital № 85 FMBA»
- OGBUZ «Medical and sanitary unit No. 2»
- FGBI «Joint Hospital and Polyclinic» Department of Presidential Affairs of the Russian Federation
- PEPTIDPRO LLC
- Edição: Nº 3 (2022)
- Páginas: 42-51
- Seção: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/277166
- DOI: https://doi.org/10.18565/urology.2022.3.42-51
- ID: 277166
Citar
Texto integral
![Acesso aberto](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Resumo
Palavras-chave
Texto integral
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Sobre autores
D. Pushkar
A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of Russiaacademician of RAS, professor, Ph.D., MD, Head of the Department of Urology, Chief urologist of the Ministry of Health of Russia Moscow, Russia
Y. Kupriyanov
A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of Russia
Email: dr.kupriyanov@mail.ru
urologist, Ph.D., Deputy Chief Urologist of Moscow Health Department, associate professor at the Department of Urology, Moscow City Hospital named after S.I. Spasokukotsky Moscow, Russia
S. Gamidov
National Medical Research Center of Obstetrics, Gynecology and Perinatology named after V.I. Kulakov of the Ministry of Health of RussiaPh.D., MD, professor, Chief of the Department of Andrology and Urology Moscow, Russia
G. Krivoborodov
Pirogov Russian National Research Medical UniversityPh.D., MD, professor at the Department of Urology and Andrology Moscow, Russia
L. Spivak
I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia; LLC «Family polyclinic No. 4»Ph.D., MD, associate professor at the Institute of Urology and Human Reproductive Health, Chief of the Department of Clinical Trials of the Drugs and Diagnostic Tests of FGAOU VO I.M. Sechenov First Moscow State Medical University, Moscow, Russia, urologist at the Family Policlinic №4 LLC, c. Korolev, Moscow Region, Russia Moscow, Russia; Moscow region, Korolev, Russia
S. Al-Shukri
FGBOU VO Pavlov First Saint Petersburg State Medical University of the Ministry of Health of the Russian Federation; LLC «MK-Med»Ph.D., MD, professor, Head of the Department of Urology Saint Petersburg, Russia
D. Lerman
LLC «Chaika Clinics»urologist, ultrasound sonographers Moscow, Russia
V. Gomberg
GBUZ «City Geriatric Health Center»Ph.D., Head of the Department of Urology Saint Petersburg, Russia
E. Bogdan
LLC «Aurora Medi»urologist Saint Petersburg, Russia
V. Shchukin
LLC «Research Center Eco-safety»urologist Saint Petersburg, Russia
K. Chibirov
FSBI «SPb NIIF» of the Ministry of Health of Russiaurologist Saint Petersburg, Russia
V. Gelashvili
FSBI «Clinical Hospital № 85 FMBA»urologist, head of the Department of Clinical Trials Moscow, Russia
A. Gural
OGBUZ «Medical and sanitary unit No. 2»urologist Tomsk, Russia
N. Keshishchev
FGBI «Joint Hospital and Polyclinic» Department of Presidential Affairs of the Russian FederationPh.D., urologist at the FGBI «Joint Hospital and Polyclinic» Department Moscow, Russia
M. Staroselskaia
PEPTIDPRO LLCmedical advisor Moscow, Russia
N. Bastrikova
PEPTIDPRO LLCPh.D. in Biology, medical director Moscow, Russia
Bibliografia
- Milsom I., Abrams P., Cardozo L. et al. How wide spread are the symptoms of an overactive bladder and how are they managed? A population based prevalence study. BJU Int, 2001, 87: 760-766.
- Пушкарь Д.Ю. Гиперактивный мочевой пузырь у женщин. М.: МЕД пресс-информ, 2003. 160 с.
- Касян Г.Р., Куприянов Ю.А., Ходырева Л.А., Дударева А.А. Синдром гиперактивного мочевого пузыря в клинической практике врача-уролога. Методические рекомендации № 13 ДЗ Москвы, 2019.
- Peyronnet B., Mironska E., Chapple C., Cardozo L., Oelke M., Dmochowski R., Amarenco G., Gamé. X, Kirby R., Van Der Aa. F., Cornu J.N. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol. 2019;75(6) :988-1000. doi: 10.1016/j.eururo.2019.02.038. Epub 2019 Mar 26. PMID: 30922690.
- Guralnick M.L., Grimsby G., Liss M. et al. Objective differences between overactive bladder patients with and without urodynamically proven detrusor overactivity.Int Urogynecol J. 2010;21:325-329.
- Haylen B.T., Chetty N., Logan V. et al. Is sensory urgency part of the same spectrum of bladder dysfunction as detrusor overactivity? Int Urogynecol J Pelvic Floor Dysfunct. 2007;18:123-128.
- Мазо Е.Б., Кривобородов Г.Г. Гиперактивный мочевой пузырь. Вече. М. 2003. 159 с.
- Любарская Ю.О., Атдуев В.А. Гиперактивный мочевой пузырь. Ремедиум Приволжье. 2014. № 5(125).
- Liu H.T., Chancellor M.B., Kuo H.C. Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection. Eur. Urol. 2009;56(4):700-706.
- Fry C.H., Vahabi B. The Role of the Mucosa in Normal and Abnormal Bladder Function. Basic Clin Pharmacol Toxicol. 2016;119:57-62. https://doi.org/10.1111/bcpt.12626
- Elbadawi A., Yalla S.V., Resnick N.M. Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity. J Urology. 1993;150(5 Pt 2):1668-1680.
- Campbell G.R., Campbell J.H. Ultrastructure of smooth muscle cells in culture. In: Ultrastructure of Smooth Muscle. Edited by P.M. Motta. Boston: Kluwer Academic Publishers, chapt. 4, 1990;79-99.
- Burnstock G. Development of smooth muscle and its innervation. In: Smooth Muscle: An Assessment of Current Knowledge. Edited by E. Bulbring, A.F. Brading, A.W. Jones and T. Tomita. Austin: University of Texas Press, chapt. 20. 1981;431-457.
- Fujii S., Konishi L., Katabuchi H., Okamura H. Ultrastructure of smooth muscle tissue in the female reproductive tract: uterus and oviduct. In: Ultrastructure of Smooth Muscle. Edited by P. M. Motta. Boston: Kluwer Academic Publishers, chapt. 10. 1990;197-220.
- Edmond Changkyun Park, Jae Sung Lim, Seung Il Kim, Sang-Yeop Lee, Yu-Kyung Tak et al. Proteomic Analysis of Urothelium of Rats with Detrusor Overactivity Induced by Bladder Outlet Obstruction, Molecular & Cellular Proteomics. 2018;17(5):948-960. ISSN 1535-9476, https://doi.org/10.1074/mcp.RA117.000290
- Birder L., Andersson K.E. Urothelial signaling. Physiological reviews. 2013;93(2):653-680. https://doi.org/10.1152/physrev.00030.2012
- Fry C.H., Young J.S., Jabr R.I., McCarthy C., Ikeda Y., Kanai A.J. Modulation of spontaneous activity in the overactive bladder: the role of P2Y agonists. American journal of physiology. Renal physiology. 2012;302( 11) :F1447-F1454. https://doi.org/10.1152/ajprenal.00436.2011
- Arms L., Vizzard M.A. Neuropeptides in Lower Urinary Tract Function. In: Andersson K.E., Michel M. (eds) Urinary Tract. Handbook of Experimental Pharmacology, vol 2011. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16499-6_19
- Apodaca G., Balestreire E., Birder L.A. The uroepithelial-associated sensory web. Kidney Int. 2007;72:1057-1064. doi: 10.1038/sj.ki.5002439.
- Хавинсон В.Х., Кузник Б.И., РыжакГ.А. Пептидные биорегуляторы- новый класс геропротекторов. Успехи геронтологии. 2013; 26(1):20-37.
- Чазов Е.И. Перспективы применения пептидов в медицине/В кн.: Перспективы биоорганической химии и молекулярной биологии. М.: Наука, 1986. С. 116-118.
- Ашмарин И.П. Регуляторные пептиды, функционально-непрерывная совокупность. Биохимия. 1986;51(4):531-545.
- Малинин В.В., Морозов В.Г. Механизмы пептидной регуляции гомеостаза. В В.С. Смирнов. Клиническая фармакология тимогена. СПб., 2003. С. 106.
- Отчет по теме «Экспериментальное исследование токсичности фармакологического вещества Везустен®. Острая токсичность, 1-й этап». СПб., 2014. 10 с.
- Отчет по теме «Экспериментальное исследование токсичности фармакологического вещества Везустен®. Острая токсичность, 2-й этап». СПб., 2014. 21 с.
- Отчет по теме «Экспериментальное исследование токсичности фармакологического вещества Везустен®. Хроническая токсичность». СПб., 2014. 102 с.
- Отчет «Мутагенные свойства Везустена». СПб., 2014. 13 с.
- Отчет «Изучение иммунотоксического действия Везустена». СПб., 2014. 11 с.
- Отчет «Изучение местнораздражающего действия Везустена». СПб., 2014. 3 с.
- Отчет «Изучение влияния Везустена на развитие спонтанных опухолей и продолжительность жизни мышей линии СВА». СПб., 2012. 23 с.
- Отчет «Изучение канцерогенной активности препарата Везустен в тесте ДНК-КОМЕТ». СПб., 2017. 26 с.
- Отчет «Изучение репродуктивной токсичности фармакологического вещества». СПб., 2017. 64 с.
- Отчет «Изучение аллергизирующих свойств Везустена». СПб., 2014. 8 с.
- Отчет о научно-исследовательской работе по теме «Изучение влияния тестонорма на органотипическую культуру различных тканей мыши». СПб., 2014. 13 с.
- Отчет о научно-исследовательской работе «Изучение влияния Везустена на гладко-мышечные клетки детрузора мочевого пузыря». СПб., 2017. 19 с.
- Пушкарь Д.Ю., Гамидов С.И., Гомберг В.Г., ГуральА.К., Евдокимов М.С., Касян Г.Р., Кузьмин И.В., Рыжак Г.А., Спивак Л.Г. Везустим: первые результаты применения в рамках клинического исследования у пациентов с гиперактивным мочевым пузырем. Экспериментальная и клиническая урология 2020;(3):34-35). https://doi.org/10.29188/2222-8543-2020-12-3-34-35
- Donoso M.V., Salas C, Sepulveda G, Lewin J, Fournier A, Huidobro-Toro JP. Involvement of ETA receptors in the facilitation by endothelin-1 of non-adrenergic non-cholinergic transmission in the rat urinary bladder. Br J Pharmacol. 1994;111(2):473-482.
- Kinder R.B., Restorick J.M., Mundy A.R. Vasoactive intestinal polypeptide in the hyper-reflexic neuropathic bladder. Br J Urol. 1985;57(3):289-291.
- Mazur U., Lepiarczyk E., Janikiewicz P., Bossowska A. Somatostatin immunoreactivity within the urinary bladder nerve fibers and paracervical ganglion urinary bladder projecting neurons in the female pig. Journal of Chemical Neuroanatomy. 2021;117:102007.
- Maggi C.A. The role of peptides in the regulation of the micturition reflex: an update. Gen Pharmacol. 1991;22(1):1-24.
Arquivos suplementares
![](/img/style/loading.gif)